Overview
Open Label Safety Study of a Birch Pollen Allergen Extract
Status:
Completed
Completed
Trial end date:
2010-08-01
2010-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This trial is performed to assess safety of a sublingual birch pollen extract.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Allergopharma GmbH & Co. KG
Criteria
Inclusion Criteria:- Allergic rhinoconjunctivitis attributable to birch pollen
- Positive SPT
- Positive EAST
Exclusion Criteria:
- Serious chronic diseases
- Other perennial allergies
- Partly controlled asthma